Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

282 Views

Favorite
Facebook
Tweet
Print

Session: Status Neutral Squabbles: Should We Prioritize Switching Suppressed PWH to Two Drugs? And Should We Ramp Up PrEP Initiation in Pharmacies?

441 - Should We Prioritize Switching Suppressed PWH to Two Drugs? - Con

Friday, October 18, 2024

3:33 PM – 3:51 PM US PT

Location: Concourse 151

Debate Style Speaker(s)

Darcy Wooten, MD, MS (she/her/hers)

Professor of Medicine
Washington University in St. Louis, MO, United States

Disclosure(s):

Darcy Wooten, MD, MS: AbbVie, Angelini, Contrafect, Cubist, Genentech, Gilead Sciences, Jansen, Medtronic, MSD, Novartis, Pfizer, and ViiV Healthcare: Advisor/Consultant (Terminated, September 20, 2023)